Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related ALB
This Healthcare ETF Is Ready To Rebound
Albemarle Appoints Karen Narwold As EVP And Chief Administrative Officer
Examining the Current State of Health Care and Skin Care Stocks (GuruFocus)
Related AAPL
Apple Comes Up Shy Of Triple Digits
Netflix Shares Are Hot Despite Not Actually Being Mentioned As An Apple Target
Apple Outspending Tesla On Cars, 'Shared Mobility' On Fast Track (Investor's Business Daily)

Analysts at Citigroup downgraded Albemarle (NYSE: ALB) from “buy” to “neutral.” The target price for Albemarle has been lowered from $74 to $71. Albemarle's shares closed at $64.67 yesterday.

Analysts at Jefferies downgraded Apple (NASDAQ: AAPL) from “buy” to “hold.” The target price for Apple has been lowered from $800 to $500. Apple's shares closed at $514.01 yesterday.

Analysts at Credit Suisse downgraded Netflix (NASDAQ: NFLX) from “outperform” to “neutral.” The target price for Netflix has been raised from $80 to $132. Netflix's shares closed at $103.26 yesterday.

UBS downgraded Veeco Instruments (NASDAQ: VECO) from “buy” to “neutral.” The target price for Veeco has been lowered from $35 to $34. Veeco's shares closed at $33.61 yesterday.

Latest Ratings for ALB

DateFirmActionFromTo
May 2016CitigroupMaintainsBuy
May 2016Deutsche BankMaintainsBuy
May 2016JefferiesMaintainsBuy

View More Analyst Ratings for ALB
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AAPL + ALB)

View Comments and Join the Discussion!